Total Debt
$544.4K
Net Debt
-$4.4M
Regencell Bioscience Holdings Limited currently has $544.4K in total debt. Net debt is -$4.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
RGC • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2025-06-30 | 0.00 | 0.00 | -0.00Net Cash | 0.01 | 9.5% |
| 2024-12-29 | 0.00 | 0.00 | 0.00 | 0.01 | 0.0% |
| 2024-06-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 1.0% |
| 2023-12-30 | 0.00 | 0.00 | -0.00Net Cash | 0.01 | 0.0% |
| 2023-06-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 3.7% |
| 2022-12-30 | 0.00 | 0.00 | 0.00 | 0.02 | 0.0% |
| 2022-06-30 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 4.3% |
| 2021-12-30 | 0.00 | 0.00 | 0.00 | 0.02 | 0.0% |
| 2021-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 1082.5% |
| 2020-12-30 | 0.00 | 0.00 | 0.00 | 0.00 | 590.1% |
| 2020-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 597.2% |
| 2019-12-30 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | — |